Mahal Jeetinder Singh
Jasper Therapeutics, Inc. · CEO and President
Mahal Jeetinder Singh is listed in filings as CEO and President at Jasper Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 10, 2026, including sale activity. Recent filings connect the profile to Jasper Therapeutics, Inc. (JSPR). The current snapshot covers public activity from Jun 12, 2024 to Feb 10, 2026. Reported amounts are shown as $675.0K to $540.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $19k900 shares | SellSep 12, 2024 | $21.23 | $0.9024 | |
| $22k900 shares | SellJun 12, 2024 | $24.16 | $0.9024 |